Shareholders are advised that Aspen is now in a position to explore options with other potential partners in order to optimise its European Commercial Pharmaceuticals business.
Click here for original article
Attachments
- Original document
- Permalink
Disclaimer
Aspen Pharmacare Holdings Ltd. published this content on 05 July 2019 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 05 July 2019 07:02:04 UTC